CHELSEA SIMPSON: Open Payments
NPI 1245730548 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 14 payments from 7 companies in 2025. Trend: 2023 $518 · 2024 $769 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 4 | $159 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Gilead Sciences, Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $27 |
| SOBI, INC | 1 | $22 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $13 |
Products named: PLUVICTO, Trodelvy, KISQALI, ENHERTU, TALVEY, Vonjo, LifeVest.
Industry payments across PA — which companies pay providers there.
